Madrigal Pharmaceuticals (MDGL) PT Raised to $536 at BofA Securities
Tweet
Share
E-mailGet Alerts MDGL Hot Sheet
Price: $507.56 --0%
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Join SI Premium – FREE
BofA Securities analyst Jason Zemansky raised the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $536.00 (from $529.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Celcuity Inc (CELC) PT Raised to $175 at Guggenheim
- Walmart (WMT) PT Lowered to $135 at Guggenheim
- Guidewire (GWRE) PT Raised to $200 at Oppenheimer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
